Haitham Abdulla1, Kenneth Smith1, Philip J Atherton1, Iskandar Idris2. 1. Division of Medical Sciences & Graduate Entry Medicine, School of Medicine, University of Nottingham, Royal Derby Hospital, Uttoxeter Road, Derby, DE22 3DT, UK. 2. Division of Medical Sciences & Graduate Entry Medicine, School of Medicine, University of Nottingham, Royal Derby Hospital, Uttoxeter Road, Derby, DE22 3DT, UK. Iskandar.Idris@nottingham.ac.uk.
Abstract
AIMS/HYPOTHESIS: We aimed to investigate the role of insulin in regulating human skeletal muscle metabolism in health and diabetes. METHODS: We conducted a systematic review and meta-analysis of published data that examined changes in skeletal muscle protein synthesis (MPS) and/or muscle protein breakdown (MPB) in response to insulin infusion. Random-effects models were used to calculate weighted mean differences (WMDs), 95% CIs and corresponding p values. Both MPS and MPB are reported in units of nmol (100 ml leg vol.)(-1) min(-1). RESULTS: A total of 104 articles were examined in detail. Of these, 44 and 25 studies (including a total of 173 individuals) were included in the systematic review and meta-analysis, respectively. In the overall estimate, insulin did not affect MPS (WMD 3.90 [95% CI -0.74, 8.55], p = 0.71), but significantly reduced MPB (WMD -15.46 [95% CI -19.74, -11.18], p < 0.001). Overall, insulin significantly increased net balance protein acquisition (WMD 20.09 [95% CI 15.93, 24.26], p < 0.001). Subgroup analysis of the effect of insulin on MPS according to amino acid (AA) delivery was performed using meta-regression analysis. The estimate size (WMD) was significantly different between subgroups based on AA availability (p = 0.001). An increase in MPS was observed when AA availability increased (WMD 13.44 [95% CI 4.07, 22.81], p < 0.01), but not when AA availability was reduced or unchanged. In individuals with diabetes and in the presence of maintained delivery of AA, there was a significant reduction in MPS in response to insulin (WMD -6.67 [95% CI -12.29, -0.66], p < 0.05). CONCLUSIONS/ INTERPRETATION: This study demonstrates the complex role of insulin in regulating skeletal muscle metabolism. Insulin appears to have a permissive role in MPS in the presence of elevated AAs, and plays a clear role in reducing MPB independent of AA availability.
AIMS/HYPOTHESIS: We aimed to investigate the role of insulin in regulating human skeletal muscle metabolism in health and diabetes. METHODS: We conducted a systematic review and meta-analysis of published data that examined changes in skeletal muscle protein synthesis (MPS) and/or muscle protein breakdown (MPB) in response to insulin infusion. Random-effects models were used to calculate weighted mean differences (WMDs), 95% CIs and corresponding p values. Both MPS and MPB are reported in units of nmol (100 ml leg vol.)(-1) min(-1). RESULTS: A total of 104 articles were examined in detail. Of these, 44 and 25 studies (including a total of 173 individuals) were included in the systematic review and meta-analysis, respectively. In the overall estimate, insulin did not affect MPS (WMD 3.90 [95% CI -0.74, 8.55], p = 0.71), but significantly reduced MPB (WMD -15.46 [95% CI -19.74, -11.18], p < 0.001). Overall, insulin significantly increased net balance protein acquisition (WMD 20.09 [95% CI 15.93, 24.26], p < 0.001). Subgroup analysis of the effect of insulin on MPS according to amino acid (AA) delivery was performed using meta-regression analysis. The estimate size (WMD) was significantly different between subgroups based on AA availability (p = 0.001). An increase in MPS was observed when AA availability increased (WMD 13.44 [95% CI 4.07, 22.81], p < 0.01), but not when AA availability was reduced or unchanged. In individuals with diabetes and in the presence of maintained delivery of AA, there was a significant reduction in MPS in response to insulin (WMD -6.67 [95% CI -12.29, -0.66], p < 0.05). CONCLUSIONS/ INTERPRETATION: This study demonstrates the complex role of insulin in regulating skeletal muscle metabolism. Insulin appears to have a permissive role in MPS in the presence of elevated AAs, and plays a clear role in reducing MPB independent of AA availability.
Entities:
Keywords:
Amino acids; Insulin; Meta-analysis; Muscle protein breakdown; Muscle protein synthesis; Systematic review
Authors: Satoshi Fujita; Blake B Rasmussen; Jerson G Cadenas; Micah J Drummond; Erin L Glynn; Fred R Sattler; Elena Volpi Journal: Diabetes Date: 2007-03-09 Impact factor: 9.461
Authors: Yorgi Mavros; Shelley Kay; Kylie A Anderberg; Michael K Baker; Yi Wang; Renru Zhao; Jacinda Meiklejohn; Mike Climstein; Anthony O'Sullivan; Nathan de Vos; Bernhard T Baune; Steven N Blair; David Simar; Kieron Rooney; Nalin Singh; Maria A Fiatarone Singh Journal: Diabetes Care Date: 2013-03-08 Impact factor: 19.112
Authors: Ranee Chatterjee; Clemontina A Davenport; Lydia Kwee; David D'Alessio; Laura P Svetkey; Pao-Hwa Lin; Cris A Slentz; Olga Ilkayeva; Johanna Johnson; David Edelman; Svati H Shah Journal: Metabolomics Date: 2020-06-18 Impact factor: 4.290
Authors: Thiago M Batista; Ruben Garcia-Martin; Weikang Cai; Masahiro Konishi; Brian T O'Neill; Masaji Sakaguchi; Jong Hun Kim; Dae Young Jung; Jason K Kim; C Ronald Kahn Journal: Cell Rep Date: 2019-03-19 Impact factor: 9.423
Authors: Nathan Hodson; Daniel W D West; Andrew Philp; Nicholas A Burd; Daniel R Moore Journal: Am J Physiol Cell Physiol Date: 2019-08-28 Impact factor: 4.249
Authors: Lydia-Ann L S Harris; Gordon I Smith; Bruce W Patterson; Raja S Ramaswamy; Adewole L Okunade; Shannon C Kelly; Lane C Porter; Samuel Klein; Jun Yoshino; Bettina Mittendorfer Journal: Diabetes Date: 2017-05-04 Impact factor: 9.461